Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension. Generally, angiotensin II receptor blockers (ARBs) such as telmisartan bind to the angiotensin II type 1 (AT1) receptors with high affinity, causing inhibition of the action of angiotensin II on vascular smooth muscle, ultimately leading to a reduction in arterial blood pressure. Recent studies suggest that telmisartan may also have PPAR-gamma agonistic properties that could potentially confer beneficial metabolic effects.
Used alone or in combination with other classes of antihypertensives for the treatment of hypertension. Also used in the treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes mellitus, as well as the treatment of congestive heart failure (only in patients who cannot tolerate ACE inhibitors).
Agents Acting on the Renin-Angiotensin System
Agents causing angioedema
Agents causing hyperkalemia
Angiotensin 2 Receptor Blocker
Angiotensin II receptor blockers (ARBs) and calcium channel blockers
Angiotensin II receptor blockers (ARBs) and diuretics
Angiotensin II receptor blockers (ARBs), plain
Angiotensin II Type 1 Receptor Blockers
Angiotensin II Type 2 Receptor Blockers
Angiotensin Receptor Antagonists
Antihypertensive Agents Indicated for Hypertension
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682